BASE THERAPEUTICS

base-therapeutics-logo

Base Therapeutics offers cell and gene editing technology designed to treat cancerous diseases. The company's technology includes a natural killer cell genetic engineering platform and other cell therapy products for treatments of lung cancer, liver cancer, glioma, and other hematological tumors

#SimilarOrganizations #Financial #Website #More

BASE THERAPEUTICS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2021-04-28

Address:
Zhuhai, Guangdong, China

Country:
China

Website Url:
http://www.basetherapeutics.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
Chinese Server Location


Similar Organizations

aristea-therapeutics-logo

Aristea Therapeutics

Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.

baisios-logo

Baisios

Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.

cstone-pharmaceuticals-logo

CStone Pharmaceuticals

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

eden-biologics-logo

Eden Biologics

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

pionyr-immunotherapeutics-logo

Pionyr Immunotherapeutics

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

susstains-logo

Susstains

Sustained efforts to create a sustainable ecosystem in the agri-tech and engineering domains.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

Investors List

guangda-huitong_image

Guangda Huitong

Guangda Huitong investment in Series A - Base Therapeutics

great-eagle-holdings-limited_image

Great Eagle Holdings Limited

Great Eagle Holdings Limited investment in Series A - Base Therapeutics

sincere-capital_image

Sincere Capital

Sincere Capital investment in Series A - Base Therapeutics

panacea-venture-bb23_image

Panacea Venture

Panacea Venture investment in Series A - Base Therapeutics

highlight-capital-llc_image

Highlight Capital

Highlight Capital investment in Series A - Base Therapeutics

baidu-ventures_image

Baidu Ventures

Baidu Ventures investment in Series A - Base Therapeutics

Official Site Inspections

http://www.basetherapeutics.com Semrush global rank: 8.21 M Semrush visits lastest month: 605

  • Host name: 139.196.144.208
  • IP address: 139.196.144.208
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Base Therapeutics"

base therapeutics-贝斯生物-上海贝斯昂科

Partnering With Us Please contact: [email protected] Career and Contact It takes a village to raise a child, and it takes a great team to build a successful company. Base …See details»

Base Therapeutics - Crunchbase Company Profile

Where is Base Therapeutics's headquarters? Base Therapeutics is located in Zhuhai, Guangdong, China. Who invested in Base Therapeutics? Base …See details»

Base Therapeutics 2025 Company Profile: Valuation, …

Information on valuation, funding, cap tables, investors, and executives for Base Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Base Therapeutics - 2025 Company Profile - Tracxn

Apr 26, 2025 Base Therapeutics - Developer of cell and gene editing technology designed to treat cancerous diseases. Raised funding over 3 rounds from 2 investors.See details»

Base Therapeutics (Shanghai) Ltd. - Drug pipelines, Patents, …

May 21, 2025 Explore Base Therapeutics (Shanghai) Ltd. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 1 news, Disease Domain:Neoplasms, Hemic and …See details»

Base Therapeutics

Hong Kong’s vibrant innovation and technology (I&T) environment provides a fertile ground for Base Therapeutics to thrive. Founded in 2021, Base Therapeutics is a health-tech enterprise …See details»

Base Therapeutics (Zhuhai) Ltd. (珠海贝斯昂科科技有限责任公司)

May 11, 2025 了解Base Therapeutics (Zhuhai) Ltd. (珠海贝斯昂科科技有限责任公司)公司的药物管线,治疗领域,技术平台,以及它的2篇新闻,疾病领域:肿瘤,血液及淋巴系统疾病,免疫 …See details»

Base Therapeutics - Products, Competitors, Financials, Employees ...

Built upon its solid DNA synthesis technology, the corporation comprises three business units: life-science services and products, a biologics contract development and manufacturing …See details»

Base Therapeutics (Zhuhai) Ltd. - Drug pipelines, Patents ... - Patsnap

May 11, 2025 Explore Base Therapeutics (Zhuhai) Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Hemic and Lymphatic Diseases ...See details»

base therapeutics-贝斯生物-上海贝斯昂科

合作机会 AccuBase在以下领域对外授权: -人类疾病诊断与治疗 -基础研究 -农业 -其他潜在领域 共同开发 我们热切希望与合作伙伴利用AccuBase及其技术,共同开发创新的细胞疗法和体内碱基编辑疗法,造福全球患者。 与我们合作 请联 …See details»

Base Therapeutics - News & Analysis - Crunchbase

News Signals Monday, December 9, 2024 PR Newswire Dec 9, 2024 FDA Grants IND Approval to Base Therapeutics' Base-Edited NK Cell Therapy, Powered by GenScript's cGMP sgRNA …See details»

The World’s First Base-edited NK Cell Therapy Receives IND

Dec 2, 2024 Base Therapeutics announced that its in house-developed NK510 cell injection—the world’s first base-edited universal NK cell product—has received IND approvals …See details»

World’s First Zero-Off-Target Base-edited NK Cell Therapy

Dec 5, 2024 Release Summary The world’s first zero-off-target base-edited NK cell product has received IND approvals from both the U.S. FDA and China’s NMPA.See details»

Base Therapeutics - VentureRadar

Base Therapeutics is a biotechnology company specializing in gene editing technologies. They have developed advanced base editors, including cytidine and adenine base editors, which …See details»

Base Therapeutics | Globenewswire

May 12, 2024 By leveraging the proprietary base editing technology, Base Therapeutics aims to revolutionize cell and gene treatment worldwide. For more information, visit …See details»

Base Therapeutics - Financial Details

Best Bio is a developer of cell therapy products and gene therapy products.See details»

Base Therapeutics - Growth Outlook - Crunchbase

Companies with Similar Growth Organization Name Growth Score Industries Headquarters Location Description Kymera Therapeutics 92 Biotechnology, Health Care, Medical, …See details»

Base Therapeutics - Profiles & Contacts - Crunchbase

Best Bio is a developer of cell therapy products and gene therapy products.See details»

World’s First Zero-Off-Target Base-edited NK Cell Therapy …

SHANGHAI, CHINA, December 5, 2024 / EINPresswire.com / -- Base Therapeutics has announced that its NK510 cell injection, the world’s first zero-off-target base-edited NK cell …See details»

Biotech Startup Tahoe Therapeutics Raised $30 Million To Build AI ...

1 day ago The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed for AI models–and use them …See details»

linkstock.net © 2022. All rights reserved